Discover medical breakthroughs and policy insights to stay informed on healthcare trends.
Healthcare
Once heralded as a trailblazer in consumer genetics, 23andMe has filed for Chapter 11 bankruptcy protection, marking a dramatic fall from its former $6 billion valuation. The filing was made Sunday night in Missouri federal court, capping off a tumultuous period for the company marked by financial struggles, failed business
Artificial Intelligence (AI)
Reid Hoffman, the billionaire entrepreneur and investor best known for co-founding LinkedIn, is now setting his sights on a new frontier: using artificial intelligence to fight cancer. His latest venture, Manas AI, aims to accelerate drug discovery and improve cancer treatments by merging cutting-edge AI with advanced biomedical research. A
Health
When it comes to maintaining mental sharpness as we age, professional expertise and personal experience both matter. Dr. Richard Restak, a neurology professor at Georgetown University and an author of over 20 books on the mind, offers the best of both worlds. At 83, he combines his deep academic knowledge
Wearables
Oura, the smart ring maker, announced it has secured $200 million in a Series D funding round, bringing its valuation to $5.2 billion. The funding round included participation from Fidelity Management and glucose monitoring device maker Dexcom. Expansion Plans and AI Focus Oura says the new capital will be
Pharmaceutical
Amazon's pharmacy business is on track to generate $2 billion in revenue this year, driven by surging customer interest in its online medication services, according to Evercore's analysis. In a recent survey conducted by Evercore, 45% of Amazon customers expressed being "extremely interested" or
Medicine
Diagnostic medicine is taking a step into the future with an innovation straight out of cyberpunk fiction. Scientists at the University of Texas at Austin have unveiled groundbreaking technology: temporary electronic tattoos capable of monitoring brain activity. This advancement could one day make diagnosing neurological conditions faster, more comfortable, and
Lifestyle
JPMorgan Chase CEO Jamie Dimon envisions a future where advancements in artificial intelligence (AI) significantly transform the workplace, leading to a reduced workweek and increased longevity. In a recent interview, Dimon predicted that the next generation of employees will work approximately 3.5 days per week and live to 100
Investing
Many baby boomers express significant regrets about their retirement planning, particularly concerning their reliance on Social Security and 401(k) plans. A survey of nearly 1,200 Americans revealed that a substantial number of respondents wish they had started saving earlier and invested more wisely. A common sentiment among boomers
Healthcare
President-elect Donald Trump has nominated Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS), the federal agency overseeing healthcare programs for over 140 million Americans. Dr. Oz, a cardiothoracic surgeon and former television host, previously ran for the U.S. Senate in Pennsylvania in 2022 with
Healthcare
Recent studies have highlighted the potential and limitations of AI models like ChatGPT in medical diagnostics. While these models can process vast amounts of data and provide rapid responses, their diagnostic accuracy varies significantly. For instance, a study published in JAMA Pediatrics found that GPT-4 had an accuracy rate of
Healthcare
Amazon has introduced a range of healthcare services under its One Medical and Amazon Pharmacy brands, specifically for Amazon Prime members. The new offerings include low-cost telehealth consultations, treatment plans, and fast, free medication delivery, focusing on common health and beauty needs. This expansion signals Amazon’s commitment to making
Business Insights
23andMe, the DNA-testing company, announced a significant restructuring on November 11, 2024, involving a 40% reduction in its workforce—over 200 employees—and the discontinuation of its therapeutics division. This move aims to stabilize the company's financial position amid ongoing challenges. The therapeutics division, which was conducting human